お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は前立腺がん治療薬市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートは前立腺がん治療薬の主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。

世界の前立腺がん治療薬市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートは前立腺がん治療薬のメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別に前立腺がん治療薬市場を分類しています。本研究に含まれる主な企業は：Johnson & Johnson、Astella、Sanofi、Ipsen、Bayer、AstraZeneca、Dendreon

地域別市場区分、地域別分析は以下の通り：
    アメリカとカナダ
    中国
    アジア
    ヨーロッパ
    中東、アフリカ、ラテンアメリカ

タイプ別市場セグメント：
    Zytiga
    Gonax
    Lupron
    Zoladex
    Decapeptyl
    Eligard
    Vantas
    Casodex
    Others

用途別の市場セグメント：
    Hospitals
    Ambulatory Surgical Centers
    Clinics

本レポートの詳細内容
世界の前立腺がん治療薬市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、前立腺がん治療薬タイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業の前立腺がん治療薬収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の前立腺がん治療薬市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、前立腺がん治療薬市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。

前立腺がん治療薬のレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。

章の概要
第1章：前立腺がん治療薬のレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント（製品タイプ、用途など）のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。（2019～2030）
第2章：前立腺がん治療薬の世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。（2019～2030）
第3章前立腺がん治療薬企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。（2019～2030）
第4章：各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2024）
第5章：前立腺がん治療薬の各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：北米（米国、カナダ）のタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第7章：ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第8章：中国の種類別、および用途別、各セグメントの収益。（2019～2030）
第9章アジア（中国を除く）の種類別、用途別、地域別、セグメントごとの収益。（2019～2030）
第10章：中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第11章：前立腺がん治療薬の主要企業の概要を提供し、製品の説明と仕様、前立腺がん治療薬の収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。（2019～2024）
第12章：アナリストの見解/結論

Adoption of innovative technologies in screening & diagnostic tests is projected to drive growth. The incorporation of multiparametric MRI (mp-MRI) can significantly improve the detection of tumor and also provide confirmation whether there is a need for tissue biopsy. In addition, market players are investing in research for the development of therapeutic products for the treatment of such tumors. For instance, there is a strong pipeline of products such as Tc-99m (Progenics), radium-223 dichloride (Xofigo, Bayer), ODM-201 (Orion and Bayer), which are in their phase 3 studies and are projected to enter the market in the near future. In addition, many generic products are likely to enter the market owing to the expiry of patents of the major existing products during the forecast period. Thus, these factors are expected to drive growth.
Market Analysis and Insights: Global Prostate Cancer Treatment Drugs Market
The global Prostate Cancer Treatment Drugs market is projected to grow from US$ 14830 million in 2024 to US$ 18760 million by 2030, at a Compound Annual Growth Rate (CAGR) of 4.0% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Prostate Cancer Treatment Drugs market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of Prostate Cancer Treatment Drugs, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Prostate Cancer Treatment Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Prostate Cancer Treatment Drugs revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Prostate Cancer Treatment Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Prostate Cancer Treatment Drugs revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Johnson & Johnson, Astella, Sanofi, Ipsen, Bayer, AstraZeneca and Dendreon, etc.

Market Segmentation
By Company
    Johnson & Johnson
    Astella
    Sanofi
    Ipsen
    Bayer
    AstraZeneca
    Dendreon

Segment by Type
    Zytiga
    Gonax
    Lupron
    Zoladex
    Decapeptyl
    Eligard
    Vantas
    Casodex
    Others

Segment by Application
    Hospitals
    Ambulatory Surgical Centers
    Clinics

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Prostate Cancer Treatment Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Prostate Cancer Treatment Drugs companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Prostate Cancer Treatment Drugs revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

List of Tables
    Table 1. Global Prostate Cancer Treatment Drugs Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Zytiga
    Table 3. Key Players of Gonax
    Table 4. Key Players of Lupron
    Table 5. Key Players of Zoladex
    Table 6. Key Players of Decapeptyl
    Table 7. Key Players of Eligard
    Table 8. Key Players of Vantas
    Table 9. Key Players of Casodex
    Table 10. Key Players of Others
    Table 11. Global Prostate Cancer Treatment Drugs Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 12. Global Prostate Cancer Treatment Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 13. Global Prostate Cancer Treatment Drugs Market Size by Region (2019-2024) & (US$ Million)
    Table 14. Global Prostate Cancer Treatment Drugs Market Share by Region (2019-2024)
    Table 15. Global Prostate Cancer Treatment Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 16. Global Prostate Cancer Treatment Drugs Market Share by Region (2025-2030)
    Table 17. Prostate Cancer Treatment Drugs Market Trends
    Table 18. Prostate Cancer Treatment Drugs Market Drivers
    Table 19. Prostate Cancer Treatment Drugs Market Challenges
    Table 20. Prostate Cancer Treatment Drugs Market Restraints
    Table 21. Global Prostate Cancer Treatment Drugs Revenue by Players (2019-2024) & (US$ Million)
    Table 22. Global Prostate Cancer Treatment Drugs Revenue Share by Players (2019-2024)
    Table 23. Global Top Prostate Cancer Treatment Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Treatment Drugs as of 2023)
    Table 24. Global Prostate Cancer Treatment Drugs Industry Ranking 2022 VS 2023 VS 2024
    Table 25. Global 5 Largest Players Market Share by Prostate Cancer Treatment Drugs Revenue (CR5 and HHI) & (2019-2024)
    Table 26. Global Key Players of Prostate Cancer Treatment Drugs, Headquarters and Area Served
    Table 27. Global Key Players of Prostate Cancer Treatment Drugs, Product and Application
    Table 28. Global Key Players of Prostate Cancer Treatment Drugs, Product and Application
    Table 29. Mergers & Acquisitions, Expansion Plans
    Table 30. Global Prostate Cancer Treatment Drugs Market Size by Type (2019-2024) & (US$ Million)
    Table 31. Global Prostate Cancer Treatment Drugs Revenue Market Share by Type (2019-2024)
    Table 32. Global Prostate Cancer Treatment Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 33. Global Prostate Cancer Treatment Drugs Revenue Market Share by Type (2025-2030)
    Table 34. Global Prostate Cancer Treatment Drugs Market Size by Application (2019-2024) & (US$ Million)
    Table 35. Global Prostate Cancer Treatment Drugs Revenue Share by Application (2019-2024)
    Table 36. Global Prostate Cancer Treatment Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 37. Global Prostate Cancer Treatment Drugs Revenue Share by Application (2025-2030)
    Table 38. North America Prostate Cancer Treatment Drugs Market Size by Type (2019-2024) & (US$ Million)
    Table 39. North America Prostate Cancer Treatment Drugs Market Size by Type (2025-2030) & (US$ Million)
    Table 40. North America Prostate Cancer Treatment Drugs Market Size by Application (2019-2024) & (US$ Million)
    Table 41. North America Prostate Cancer Treatment Drugs Market Size by Application (2025-2030) & (US$ Million)
    Table 42. North America Prostate Cancer Treatment Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 43. North America Prostate Cancer Treatment Drugs Market Size by Country (2019-2024) & (US$ Million)
    Table 44. North America Prostate Cancer Treatment Drugs Market Size by Country (2025-2030) & (US$ Million)
    Table 45. Europe Prostate Cancer Treatment Drugs Market Size by Type (2019-2024) & (US$ Million)
    Table 46. Europe Prostate Cancer Treatment Drugs Market Size by Type (2025-2030) & (US$ Million)
    Table 47. Europe Prostate Cancer Treatment Drugs Market Size by Application (2019-2024) & (US$ Million)
    Table 48. Europe Prostate Cancer Treatment Drugs Market Size by Application (2025-2030) & (US$ Million)
    Table 49. Europe Prostate Cancer Treatment Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 50. Europe Prostate Cancer Treatment Drugs Market Size by Country (2019-2024) & (US$ Million)
    Table 51. Europe Prostate Cancer Treatment Drugs Market Size by Country (2025-2030) & (US$ Million)
    Table 52. China Prostate Cancer Treatment Drugs Market Size by Type (2019-2024) & (US$ Million)
    Table 53. China Prostate Cancer Treatment Drugs Market Size by Type (2025-2030) & (US$ Million)
    Table 54. China Prostate Cancer Treatment Drugs Market Size by Application (2019-2024) & (US$ Million)
    Table 55. China Prostate Cancer Treatment Drugs Market Size by Application (2025-2030) & (US$ Million)
    Table 56. Asia Prostate Cancer Treatment Drugs Market Size by Type (2019-2024) & (US$ Million)
    Table 57. Asia Prostate Cancer Treatment Drugs Market Size by Type (2025-2030) & (US$ Million)
    Table 58. Asia Prostate Cancer Treatment Drugs Market Size by Application (2019-2024) & (US$ Million)
    Table 59. Asia Prostate Cancer Treatment Drugs Market Size by Application (2025-2030) & (US$ Million)
    Table 60. Asia Prostate Cancer Treatment Drugs Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 61. Asia Prostate Cancer Treatment Drugs Market Size by Region (2019-2024) & (US$ Million)
    Table 62. Asia Prostate Cancer Treatment Drugs Market Size by Region (2025-2030) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Prostate Cancer Treatment Drugs Market Size by Type (2019-2024) & (US$ Million)
    Table 64. Middle East, Africa, and Latin America Prostate Cancer Treatment Drugs Market Size by Type (2025-2030) & (US$ Million)
    Table 65. Middle East, Africa, and Latin America Prostate Cancer Treatment Drugs Market Size by Application (2019-2024) & (US$ Million)
    Table 66. Middle East, Africa, and Latin America Prostate Cancer Treatment Drugs Market Size by Application (2025-2030) & (US$ Million)
    Table 67. Middle East, Africa, and Latin America Prostate Cancer Treatment Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 68. Middle East, Africa, and Latin America Prostate Cancer Treatment Drugs Market Size by Country (2019-2024) & (US$ Million)
    Table 69. Middle East, Africa, and Latin America Prostate Cancer Treatment Drugs Market Size by Country (2025-2030) & (US$ Million)
    Table 70. Johnson & Johnson Company Details
    Table 71. Johnson & Johnson Business Overview
    Table 72. Johnson & Johnson Prostate Cancer Treatment Drugs Product
    Table 73. Johnson & Johnson Revenue in Prostate Cancer Treatment Drugs Business (2019-2024) & (US$ Million)
    Table 74. Johnson & Johnson Recent Developments
    Table 75. Astella Company Details
    Table 76. Astella Business Overview
    Table 77. Astella Prostate Cancer Treatment Drugs Product
    Table 78. Astella Revenue in Prostate Cancer Treatment Drugs Business (2019-2024) & (US$ Million)
    Table 79. Astella Recent Developments
    Table 80. Sanofi Company Details
    Table 81. Sanofi Business Overview
    Table 82. Sanofi Prostate Cancer Treatment Drugs Product
    Table 83. Sanofi Revenue in Prostate Cancer Treatment Drugs Business (2019-2024) & (US$ Million)
    Table 84. Sanofi Recent Developments
    Table 85. Ipsen Company Details
    Table 86. Ipsen Business Overview
    Table 87. Ipsen Prostate Cancer Treatment Drugs Product
    Table 88. Ipsen Revenue in Prostate Cancer Treatment Drugs Business (2019-2024) & (US$ Million)
    Table 89. Ipsen Recent Developments
    Table 90. Bayer Company Details
    Table 91. Bayer Business Overview
    Table 92. Bayer Prostate Cancer Treatment Drugs Product
    Table 93. Bayer Revenue in Prostate Cancer Treatment Drugs Business (2019-2024) & (US$ Million)
    Table 94. Bayer Recent Developments
    Table 95. AstraZeneca Company Details
    Table 96. AstraZeneca Business Overview
    Table 97. AstraZeneca Prostate Cancer Treatment Drugs Product
    Table 98. AstraZeneca Revenue in Prostate Cancer Treatment Drugs Business (2019-2024) & (US$ Million)
    Table 99. AstraZeneca Recent Developments
    Table 100. Dendreon Company Details
    Table 101. Dendreon Business Overview
    Table 102. Dendreon Prostate Cancer Treatment Drugs Product
    Table 103. Dendreon Revenue in Prostate Cancer Treatment Drugs Business (2019-2024) & (US$ Million)
    Table 104. Dendreon Recent Developments
    Table 105. Research Programs/Design for This Report
    Table 106. Key Data Information from Secondary Sources
    Table 107. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Prostate Cancer Treatment Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Prostate Cancer Treatment Drugs Market Share by Type: 2023 VS 2030
    Figure 3. Zytiga Features
    Figure 4. Gonax Features
    Figure 5. Lupron Features
    Figure 6. Zoladex Features
    Figure 7. Decapeptyl Features
    Figure 8. Eligard Features
    Figure 9. Vantas Features
    Figure 10. Casodex Features
    Figure 11. Others Features
    Figure 12. Global Prostate Cancer Treatment Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 13. Global Prostate Cancer Treatment Drugs Market Share by Application: 2023 VS 2030
    Figure 14. Hospitals Case Studies
    Figure 15. Ambulatory Surgical Centers Case Studies
    Figure 16. Clinics Case Studies
    Figure 17. Prostate Cancer Treatment Drugs Report Years Considered
    Figure 18. Global Prostate Cancer Treatment Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 19. Global Prostate Cancer Treatment Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 20. Global Prostate Cancer Treatment Drugs Market Share by Region: 2023 VS 2030
    Figure 21. Global Prostate Cancer Treatment Drugs Market Share by Players in 2023
    Figure 22. Global Top Prostate Cancer Treatment Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Treatment Drugs as of 2023)
    Figure 23. The Top 10 and 5 Players Market Share by Prostate Cancer Treatment Drugs Revenue in 2023
    Figure 24. North America Prostate Cancer Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. North America Prostate Cancer Treatment Drugs Market Share by Type (2019-2030)
    Figure 26. North America Prostate Cancer Treatment Drugs Market Share by Application (2019-2030)
    Figure 27. North America Prostate Cancer Treatment Drugs Market Share by Country (2019-2030)
    Figure 28. United States Prostate Cancer Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Canada Prostate Cancer Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Europe Prostate Cancer Treatment Drugs Market Size YoY (2019-2030) & (US$ Million)
    Figure 31. Europe Prostate Cancer Treatment Drugs Market Share by Type (2019-2030)
    Figure 32. Europe Prostate Cancer Treatment Drugs Market Share by Application (2019-2030)
    Figure 33. Europe Prostate Cancer Treatment Drugs Market Share by Country (2019-2030)
    Figure 34. Germany Prostate Cancer Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. France Prostate Cancer Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. U.K. Prostate Cancer Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Italy Prostate Cancer Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. Russia Prostate Cancer Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. Nordic Countries Prostate Cancer Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. China Prostate Cancer Treatment Drugs Market Size YoY (2019-2030) & (US$ Million)
    Figure 41. China Prostate Cancer Treatment Drugs Market Share by Type (2019-2030)
    Figure 42. China Prostate Cancer Treatment Drugs Market Share by Application (2019-2030)
    Figure 43. Asia Prostate Cancer Treatment Drugs Market Size YoY (2019-2030) & (US$ Million)
    Figure 44. Asia Prostate Cancer Treatment Drugs Market Share by Type (2019-2030)
    Figure 45. Asia Prostate Cancer Treatment Drugs Market Share by Application (2019-2030)
    Figure 46. Asia Prostate Cancer Treatment Drugs Market Share by Region (2019-2030)
    Figure 47. Japan Prostate Cancer Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. South Korea Prostate Cancer Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. China Taiwan Prostate Cancer Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 50. Southeast Asia Prostate Cancer Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 51. India Prostate Cancer Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. Australia Prostate Cancer Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Middle East, Africa, and Latin America Prostate Cancer Treatment Drugs Market Size YoY (2019-2030) & (US$ Million)
    Figure 54. Middle East, Africa, and Latin America Prostate Cancer Treatment Drugs Market Share by Type (2019-2030)
    Figure 55. Middle East, Africa, and Latin America Prostate Cancer Treatment Drugs Market Share by Application (2019-2030)
    Figure 56. Middle East, Africa, and Latin America Prostate Cancer Treatment Drugs Market Share by Country (2019-2030)
    Figure 57. Brazil Prostate Cancer Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. Mexico Prostate Cancer Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 59. Turkey Prostate Cancer Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 60. Saudi Arabia Prostate Cancer Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 61. Israel Prostate Cancer Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 62. GCC Countries Prostate Cancer Treatment Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 63. Johnson & Johnson Revenue Growth Rate in Prostate Cancer Treatment Drugs Business (2019-2024)
    Figure 64. Astella Revenue Growth Rate in Prostate Cancer Treatment Drugs Business (2019-2024)
    Figure 65. Sanofi Revenue Growth Rate in Prostate Cancer Treatment Drugs Business (2019-2024)
    Figure 66. Ipsen Revenue Growth Rate in Prostate Cancer Treatment Drugs Business (2019-2024)
    Figure 67. Bayer Revenue Growth Rate in Prostate Cancer Treatment Drugs Business (2019-2024)
    Figure 68. AstraZeneca Revenue Growth Rate in Prostate Cancer Treatment Drugs Business (2019-2024)
    Figure 69. Dendreon Revenue Growth Rate in Prostate Cancer Treatment Drugs Business (2019-2024)
    Figure 70. Bottom-up and Top-down Approaches for This Report
    Figure 71. Data Triangulation
    Figure 72. Key Executives Interviewed